BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Wei C, Guo CC, Bi RX, Xie J, Guan DH, Yang CH, Jiang YH. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis. Oncotarget 2017;8:107237-57. [PMID: 29291025 DOI: 10.18632/oncotarget.20883] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, Xu Q, Ni C, Ye S, Xu X, Hu X, Jiang J, Hong Y, Huang D, Yang L. Prospects of Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2018;2018:6579436. [PMID: 30148169 DOI: 10.1155/2018/6579436] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
2 Zhu Y, Liu Y, Xiao B, Cai H, Liu M, Ma L, Yin H, Wang F. The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma. Biol Open 2019;8:bio043687. [PMID: 31551242 DOI: 10.1242/bio.043687] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
3 Ziogas IA, Sioutas G, Mylonas KS, Tsoulfas G. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma. Microrna 2020;9:25-40. [PMID: 31218966 DOI: 10.2174/2211536608666190619155406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Zeinali T, Karimi L, Hosseinahli N, Shanehbandi D, Mansoori B, Mohammadi A, Hajiasgharzadeh K, Babaloo Z, Majidi-Zolbanin J, Baradaran B. Overexpression of miRNA-145 induces apoptosis and prevents proliferation and migration of MKN-45 gastric cancer cells. EXCLI J 2020;19:1446-58. [PMID: 33250681 DOI: 10.17179/excli2020-2777] [Reference Citation Analysis]
5 Hussain S, Tulsyan S, Dar SA, Sisodiya S, Abiha U, Kumar R, Mishra BN, Haque S. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy. Semin Cancer Biol 2021:S1044-579X(21)00193-0. [PMID: 34182144 DOI: 10.1016/j.semcancer.2021.06.023] [Reference Citation Analysis]
6 Li Y, Li C, Li D, Yang L, Jin J, Zhang B. lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway. Onco Targets Ther. 2019;12:2649-2660. [PMID: 31040703 DOI: 10.2147/ott.s188054] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 20.0] [Reference Citation Analysis]
7 Lv D, Chen L, Du L, Zhou L, Tang H. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:691410. [PMID: 34368140 DOI: 10.3389/fcell.2021.691410] [Reference Citation Analysis]
8 Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M, Goldani F, Parizadeh SMR, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Avan A. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Curr Drug Targets 2019;20:1129-40. [PMID: 30848198 DOI: 10.2174/1389450120666190307095720] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
9 Martinez M, Rossetto IMU, Arantes RMS, Lizarte FSN, Tirapelli LF, Tirapelli DPC, Chuffa LGA, Martinez FE. Serum miRNAs are differentially altered by ethanol and caffeine consumption in rats. Toxicol Res (Camb) 2019;8:842-9. [PMID: 32055392 DOI: 10.1039/c9tx00069k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jiang C, Liu X, Wang M, Lv G, Wang G. High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD1)-Mediated Function of T Cells. Oncol Res 2019;27:1025-34. [PMID: 30982498 DOI: 10.3727/096504018X15456687424096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
11 Melnik BC. Dairy consumption and hepatocellular carcinoma risk. Ann Transl Med 2021;9:736. [PMID: 33987434 DOI: 10.21037/atm-2020-ubih-06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dawood AA, Saleh AA, Elbahr O, Gohar SF, Habieb MS. Inverse relationship between the level of miRNA 148a-3p and both TGF-β1 and FIB-4 in hepatocellular carcinoma. Biochem Biophys Rep 2021;27:101082. [PMID: 34355070 DOI: 10.1016/j.bbrep.2021.101082] [Reference Citation Analysis]
13 Krupa R, Malecki W, Czarny P, Strycharz J, Jablkowski M, Kordek R, Szemraj J, Sliwinski T. MicroRNA profile and iron-related gene expression in hepatitis C-related hepatocellular carcinoma: a preliminary study. Arch Med Sci 2021;17:1175-83. [PMID: 34522246 DOI: 10.5114/aoms.2019.86613] [Reference Citation Analysis]
14 Lin XQ, Huang ZM, Chen X, Wu F, Wu W. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p. Yonsei Med J 2018;59:816-26. [PMID: 30091314 DOI: 10.3349/ymj.2018.59.7.816] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
15 Liu Z, Ding F, Shen X. Total flavonoids of Radix Tetrastigma suppress inflammation-related hepatocellular carcinoma cell metastasis. Mol Genet Genomics 2021;296:571-9. [PMID: 33576897 DOI: 10.1007/s00438-020-01759-6] [Reference Citation Analysis]
16 Zhang W, Qian S, Yang G, Zhu L, Zhou B, Wang J, Liu R, Yan Z, Qu X. MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma. Gene 2018;659:22-8. [PMID: 29559347 DOI: 10.1016/j.gene.2018.03.053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
17 Heo MJ, Yun J, Kim SG. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. Arch Pharm Res 2019;42:48-62. [PMID: 30610616 DOI: 10.1007/s12272-018-01104-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]